College of Medicine
Bruggeman Diabetes Research Group
Led by Brittany Bruggeman · Pediatrics
What we study
The Bruggeman Lab studies type 1 diabetes and exocrine pancreatic dysfunction, focusing on improving patient care and developing non-invasive screening tools. Research involves clinical trials, patient data analysis, and studies on pancreatic dysfunction in diabetes.
What working here is like
- Clinical
- Computational
- Human participants
- Coding helps
- Projects
- 4
Current projects
INHALE-1st: Technosphere Insulin (Afrezza?) In Combination With Basal Insulin For Youth With Newly-Diagnosed Type 1 Diabetes
A phase 1 clinical trial testing a new insulin delivery method for newly diagnosed type 1 diabetes patients.
A Non-Invasive Patient-Reported Symptom Screening Tool (EPI/PEI-SS) to Identify Exocrine Pancreatic Insufficiency (EPI) in Type 1 Diabetes
Developing a tool to screen for pancreatic dysfunction in type 1 diabetes patients.
Show 2 more projectsShow fewer
Natural History and Mechanisms of Exocrine Pancreatic Dysfunction in Pre-Type 1 Diabetes
Studying pancreatic dysfunction in individuals at risk of developing type 1 diabetes.
Longitudinal Assessment of Exocrine Pancreatic Function and Fecal Elastase 1 as a Biomarker for Early Type 1 Diabetes Prediction
The lab studies whether a stool test called fecal elastase‑1 can predict type 1 diabetes before it starts. Students will analyze data from the TEDDY cohort to track how this marker changes in children who develop diabetes or stay healthy.
From the Spring 2025 UF Undergraduate Research Symposium · abstract book, p. 380
Summaries are written by AI in plain language from public symposium abstracts and may be imperfect.
How to reach out
Brittany Bruggeman hasn't set up this page yet. You can also look them up in the UF directory (search “Brittany Bruggeman”).